334 related articles for article (PubMed ID: 9769333)
1. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.
Shankar R; Zhu JS; Ladd B; Henry D; Shen HQ; Baron AD
J Clin Invest; 1998 Oct; 102(7):1403-12. PubMed ID: 9769333
[TBL] [Abstract][Full Text] [Related]
2. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, affects the central nervous system to produce peripheral hyperglycemia in conscious rats.
Uemura K; Tamagawa T; Chen Y; Maeda N; Yoshioka S; Itoh K; Miura H; Iguchi A; Hotta N
Neuroendocrinology; 1997 Aug; 66(2):136-44. PubMed ID: 9263211
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats.
Baron AD; Zhu JS; Marshall S; Irsula O; Brechtel G; Keech C
Am J Physiol; 1995 Oct; 269(4 Pt 1):E709-15. PubMed ID: 7485485
[TBL] [Abstract][Full Text] [Related]
4. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
Artery; 1998; 23(1):1-9. PubMed ID: 10846613
[TBL] [Abstract][Full Text] [Related]
5. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
[TBL] [Abstract][Full Text] [Related]
6. The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats.
Koshinaka K; Oshida Y; Han YQ; Ohsawa I; Sato Y
Metabolism; 2004 Jan; 53(1):22-7. PubMed ID: 14681837
[TBL] [Abstract][Full Text] [Related]
7. Prolonged NOS inhibition in the brain elevates blood pressure in normotensive rats.
Sakima A; Teruya H; Yamazato M; Matayoshi R; Muratani H; Fukiyama K
Am J Physiol; 1998 Aug; 275(2):R410-7. PubMed ID: 9688675
[TBL] [Abstract][Full Text] [Related]
8. Effects of imidapril, an angiotensin-converting enzyme inhibitor, on insulin sensitivity and responsiveness in streptozotocin-induced diabetic rats.
Viana AY; Oshida Y; Han YQ; Koshinaka K; Sato Y
Horm Metab Res; 2004 Jan; 36(1):34-8. PubMed ID: 14983404
[TBL] [Abstract][Full Text] [Related]
9. Effects of central administration of insulin or l-NMMA on rat skeletal muscle microvascular perfusion.
Bradley EA; Willson KJ; Choi-Lundberg D; Clark MG; Rattigan S
Diabetes Obes Metab; 2010 Oct; 12(10):900-8. PubMed ID: 20920043
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide regulates insulin secretion in the isolated perfused human pancreas via a cholinergic mechanism.
Atiya A; Cohen G; Ignarro L; Brunicardi FC
Surgery; 1996 Aug; 120(2):322-7. PubMed ID: 8751600
[TBL] [Abstract][Full Text] [Related]
11. The insulin secretory response to intravenous glucose in the rat is independent of NO formation.
Jun T; Sakinis A; Wennmalm A
Acta Physiol Scand; 1995 Sep; 155(1):61-5. PubMed ID: 8553878
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitric oxide synthesis attenuates insulin-mediated sympathetic activation in rats.
Muntzel MS; Malena H; Drüeke T
J Hypertens; 2001 Sep; 19(9):1625-31. PubMed ID: 11564983
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice.
Zhao GM; Bhargava HN
Peptides; 1996; 17(4):619-23. PubMed ID: 8804071
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in salivary secretion.
Lomniczi A; Suburo AM; Elverdin JC; Mastronardi CA; Diaz S; Rettori V; McCann SM
Neuroimmunomodulation; 1998; 5(5):226-33. PubMed ID: 9730690
[TBL] [Abstract][Full Text] [Related]
15. N(G)-monomethyl-L-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly.
Meneilly GS; Elliott T; Battistini B; Floras JS
Metabolism; 2001 Mar; 50(3):306-10. PubMed ID: 11230783
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of nitric oxide synthase modulation on porcine systemic and pulmonary circulation in vivo.
Dahm P; Thörne J; Zoucas E; Mårtensson L; Myhre E; Blomquist S
Crit Care Med; 1997 Feb; 25(2):280-5. PubMed ID: 9034265
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
18. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.
Joshi S; Young WL; Duong DH; Ostapkovich ND; Aagaard BD; Hashimoto T; Pile-Spellman J
Anesthesiology; 2000 Sep; 93(3):699-707. PubMed ID: 10969303
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release.
Henningsson R; Salehi A; Lundquist I
Am J Physiol Cell Physiol; 2002 Jul; 283(1):C296-304. PubMed ID: 12055099
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide generation: normalization of in vitro insulin secretion in mice with multiple low-dose streptozotocin and in mice injected with mononuclear splenocytes from diabetic syngeneic donors.
Karabatas LM; Fabiano de Bruno L; Pastorale CF; Cullen C; Basabe JC
Metabolism; 1996 Aug; 45(8):940-6. PubMed ID: 8769348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
